دورية أكاديمية
أعرض في EDS

COVID-19 vaccination and corneal allograft rejection- a review.

التفاصيل البيبلوغرافية
العنوان: COVID-19 vaccination and corneal allograft rejection- a review.
المؤلفون: Allen NE; Department of Ophthalmology, New Zealand National Eye Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Zhang J; Department of Ophthalmology, New Zealand National Eye Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., McGhee CNJ; Department of Ophthalmology, New Zealand National Eye Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
المصدر: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2023 Dec 15; Vol. 13, pp. 1307655. Date of Electronic Publication: 2023 Dec 15 (Print Publication: 2023).
نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Lausanne : Frontiers Media SA
مواضيع طبية MeSH: COVID-19*/prevention & control , Corneal Diseases*/surgery , Corneal Transplantation*, Humans ; COVID-19 Vaccines/adverse effects ; Retrospective Studies ; Systematic Reviews as Topic ; Vaccination/adverse effects ; Graft Rejection/prevention & control ; Graft Rejection/diagnosis ; Graft Rejection/etiology
مستخلص: Aim: To provide a comprehensive literature review on the perceived correlation between COVID-19 vaccination and corneal allograft rejection, and to characterize risk factors, time course, graft outcomes and proposed immunological basis.
Methods: A literature review was conducted in August 2023 using 4 electronic databases: PubMed, EMBASE, MEDLINE and Scopus. Articles were sourced using key words associated with COVID-19 vaccination and corneal graft. All articles were screened for relevance by abstract review. Duplicates and articles related to COVID-19 infection were excluded. No time limits were set. Additional literature searches regarding cause of corneal graft rejection, rates of graft rejection associated with other vaccines and the cellular mechanism of rejection were also performed.
Results: 262 articles were identified from the literature search. 37 papers were included in the analysis based on defined inclusion criteria. This consisted of systematic reviews (n=6), review articles (n=5), retrospective studies (n=3), case series (n=8), letter to the editor (n=1) and case reports (n= 14). The majority of reported allograft rejections were in penetrating keratoplasties. Risk factors for COVID-19 vaccination associated rejection were previous allograft rejection episodes, repeat grafts and penetrating keratoplasty. Most reported rejection episodes were mild and resolved with treatment. Notably, several studies reported nil increase in corneal allograft rejection episodes over the COVID-19 vaccination period. Rejection episodes are associated with a broad spectrum of other vaccines and the complete pathophysiology is undetermined.
Conclusion: Corneal allograft rejection appears to be a rare complication of COVID-19 vaccination most frequently observed in high-risk corneal transplants. The true extent of this correlation remains controversial; however, clinician awareness of this risk is essential to its mitigation. Patient counselling around symptom monitoring following vaccination and discussion around topical steroid prophylaxis may be prudent.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2023 Allen, Zhang and McGhee.)
References: Cornea. 2021 Aug 1;40(8):1070-1072. (PMID: 34029238)
Vaccines (Basel). 2022 Aug 10;10(8):. (PMID: 36016180)
Nat Immunol. 2006 Apr;7(4):354-9. (PMID: 16550198)
J Clin Med. 2022 Nov 18;11(22):. (PMID: 36431307)
Am J Ophthalmol. 2022 Aug;240:79-98. (PMID: 35227700)
Eye (Lond). 2022 Jun;36(6):1319-1320. (PMID: 34426655)
Front Immunol. 2021 Nov 09;12:747830. (PMID: 34858404)
Nature. 2021 Jul;595(7868):572-577. (PMID: 34044428)
Curr Opin Ophthalmol. 2021 Jul 1;32(4):331-337. (PMID: 33989234)
J Clin Med. 2022 Aug 02;11(15):. (PMID: 35956115)
Indian J Ophthalmol. 2023 May;71(5):1733-1738. (PMID: 37203024)
Vaccines (Basel). 2023 May 06;11(5):. (PMID: 37243058)
Br J Ophthalmol. 2017 Jun;101(6):834-838. (PMID: 27635063)
Curr Eye Res. 2007 Dec;32(12):1005-16. (PMID: 18085464)
Indian J Ophthalmol. 2022 Jan;70(1):319-321. (PMID: 34937268)
JAMA. 2020 Aug 25;324(8):782-793. (PMID: 32648899)
Cornea. 2022 Feb 1;41(2):257-259. (PMID: 34690266)
Indian J Ophthalmol. 2022 May;70(5):1817-1818. (PMID: 35502082)
Br J Ophthalmol. 2006 Jul;90(7):925. (PMID: 16782961)
Vaccines (Basel). 2023 Jan 12;11(1):. (PMID: 36680010)
Oman J Ophthalmol. 2013 Sep;6(Suppl 1):S12-7. (PMID: 24391366)
Cornea. 2022 May 1;41(5):651-653. (PMID: 35383621)
Nature. 2023 Jan;613(7942):130-137. (PMID: 36517599)
Acta Ophthalmol. 2023 Feb;101(1):e1-e13. (PMID: 35781792)
Br J Ophthalmol. 2023 Dec 18;108(1):17-22. (PMID: 36575625)
Vaccines (Basel). 2022 Feb 21;10(2):. (PMID: 35214800)
Med Arch. 2022 Apr;76(2):146-148. (PMID: 35774041)
Semin Ophthalmol. 2023 Aug;38(6):565-571. (PMID: 36688666)
Eur J Ophthalmol. 2023 Nov;33(6):NP19-NP22. (PMID: 36872625)
N Engl J Med. 2022 Sep 15;387(11):1011-1020. (PMID: 36044620)
Curr Opin Ophthalmol. 2022 Jul 1;33(4):296-305. (PMID: 35779053)
Br J Ophthalmol. 2021 Aug;105(8):1049-1058. (PMID: 32788325)
Asia Pac J Ophthalmol (Phila). 2019 Nov-Dec;8(6):441-447. (PMID: 31789646)
Indian J Ophthalmol. 2021 Dec;69(12):3398-3420. (PMID: 34826968)
Prog Retin Eye Res. 2019 Sep;72:100758. (PMID: 31014973)
Cornea. 2021 Dec 1;40(12):1541-1547. (PMID: 34749379)
Eye Contact Lens. 2021 Nov 1;47(11):625-628. (PMID: 34516456)
Indian J Ophthalmol. 2021 Jul;69(7):1953-1954. (PMID: 34146066)
Cornea. 2022 Dec 1;41(12):1536-1538. (PMID: 35965396)
Nat Rev Immunol. 2003 Nov;3(11):879-89. (PMID: 14668804)
Eur J Ophthalmol. 2021 Nov 26;:11206721211064033. (PMID: 34825599)
J Family Med Prim Care. 2022 Sep;11(9):5041-5054. (PMID: 36505575)
Korean J Ophthalmol. 2023 Feb;37(1):85-87. (PMID: 36281573)
J Fr Ophtalmol. 2021 Oct;44(8):e445-e447. (PMID: 34281760)
Vaccines (Basel). 2021 Nov 03;9(11):. (PMID: 34835205)
Case Rep Ophthalmol. 2022 Jul 15;13(2):562-569. (PMID: 36160489)
Br J Ophthalmol. 2021 Jul;105(7):893-896. (PMID: 33910885)
Am J Ophthalmol. 1988 Nov 15;106(5):575-8. (PMID: 3056015)
N Engl J Med. 2020 Dec 17;383(25):2427-2438. (PMID: 32991794)
Indian J Ophthalmol. 2021 Dec;69(12):3757-3758. (PMID: 34827040)
Ocul Immunol Inflamm. 2023 Aug;31(6):1226-1229. (PMID: 35914312)
Cornea. 2021 Nov 1;40(11):1374-1376. (PMID: 34294639)
Cornea. 2022 Apr 1;41(4):502-504. (PMID: 34907940)
Int Med Case Rep J. 2022 Apr 14;15:201-204. (PMID: 35444474)
Indian J Ophthalmol. 2022 Aug;70(8):3134-3136. (PMID: 35918988)
Clin Exp Ophthalmol. 2019 Nov;47(8):987-994. (PMID: 31268240)
Ocul Immunol Inflamm. 2022 Jul;30(5):1207-1210. (PMID: 33507830)
Vaccines (Basel). 2021 Nov 27;9(12):. (PMID: 34960150)
Mol Vis. 2005 Aug 29;11:632-40. (PMID: 16145544)
Cornea. 2022 May 1;41(5):669-672. (PMID: 35383622)
Nat Rev Immunol. 2007 Jan;7(1):52-63. (PMID: 17186031)
Ophthalmology. 2023 May;130(5):501-508. (PMID: 36538991)
Eye (Lond). 2023 Aug;37(11):2316-2319. (PMID: 36481958)
Surv Ophthalmol. 2007 Jul-Aug;52(4):375-96. (PMID: 17574064)
Cornea. 2022 Jan 1;41(1):121-124. (PMID: 34620770)
فهرسة مساهمة: Keywords: COVID-19; cornea; keratoplasty; rejection; vaccination
المشرفين على المادة: 0 (COVID-19 Vaccines)
تواريخ الأحداث: Date Created: 20240101 Date Completed: 20240103 Latest Revision: 20240223
رمز التحديث: 20240223
مُعرف محوري في PubMed: PMC10757323
DOI: 10.3389/fcimb.2023.1307655
PMID: 38162575
قاعدة البيانات: MEDLINE
الوصف
تدمد:2235-2988
DOI:10.3389/fcimb.2023.1307655